Printer Friendly

Browse Hepatitis C virus topic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
GxAlert Adds HCV Data Transmission and Alert Capabilities. Oct 18, 2017 561
AbbVie to Present Mavyret (glecaprevir/pibrentasvir) Data. Oct 12, 2017 225
AbbVie Demonstrates Leadership in HCV with New MAVYRET(TM) (glecaprevir/pibrentasvir) Data to be Presented at The Liver Meeting 2017. Oct 11, 2017 1972
United States : Merck Discontinues MK-3682B and MK-3682C Development Programs. Sep 30, 2017 200
Egyptian-American HCV drug to be available soon. Sep 30, 2017 257
AbbVie Announces Approval of MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6) in Japan. Sep 27, 2017 1856
AbbVie wins Japaneses MHLW approval for MAVIRET to treat chronic hepatitis C in all major genotypes (GT1-6). Sep 27, 2017 300
AbbVie wins Japaneses MHLW approval for MAVIRET to treat chronic hepatitis C in all major genotypes (GT1-6). Sep 27, 2017 296
3 cups of coffee a day keep HIV death risk at bay. Sep 26, 2017 411
Global Hepatitis Testing Markets to 2021. Sep 18, 2017 578
Global Hepatitis Testing Markets to 2021. Sep 18, 2017 612
Health Ministry launches 70 new HCV medication outlets. Sep 10, 2017 202
Another HCV infection after HCV cure most frequent in high risk takers. Sep 1, 2017 1853
Rapid virological and End treatment response of patients treated with Sofosbuvir in Chronic Hepatitis C. Aug 31, 2017 3175
Hepatitis C Virus Envelope Protein E2 - Pipeline Review, H2 2017. Aug 29, 2017 703
Prevalence of transfusion-transmitted infections in blood donors in a tertiary care centre. Kala V.L.; Usha, Kumari K.C.; Prema N.S.; Sajith, V. Aug 28, 2017 4285
170/17-pea "reagents, Reagents For Serological Tests By Elisa For The Marker Of Hepatitis B Virus (hbsag), Hepatitis C Virus (a-hcv), Hiv Infection, Syphilis For Blood Donor Screening", Lot 4. Aug 28, 2017 109
Diplomat to supply MAVYRET oral tablets to chronic hepatitis C virus infected patients. Aug 18, 2017 181
Diplomat to supply MAVYRET oral tablets to chronic hepatitis C virus infected patients. Aug 18, 2017 177
Diplomat Pharmacy Begins Dispensing Chronic Hepatitis C Treatment. Aug 18, 2017 198
Diplomat Dispensing MAVYRET(TM) to Treat Chronic Hepatitis C. Aug 17, 2017 616
Diesel Exhaust Fluid Market Worth 21.57 Billion USD by 2022. Aug 16, 2017 1279
Diesel Exhaust Fluid Market Worth 21.57 Billion USD by 2022. Aug 16, 2017 1283
AbbVie receives US FDA approval for Mavyret. Aug 8, 2017 298
Gilead's Vosevi hepatitis C drug approved. Aug 7, 2017 137
Seroprevalence of HSV, HBSAg & HCV in STD clinic attendees of a tertiary care state headquarters hospital. Godha, Venkata Ramana; Prasad, J. V. D. S.; Kuman, Veena; Pinjala, Padmaja; Ananthula, Venkata Krish Report Aug 7, 2017 4398
Hepatitis: A silent but a dangerous disease. Aug 6, 2017 920
US FDA Approves of AbbVie's Mavret for the Treatment of Chronic Hepatitis C in All Major Genotypes. Aug 4, 2017 387
AbbVie Inc wins US FDA's approval for Mavyret for treating Hepatitis C. Aug 4, 2017 290
United States : AbbVie Receives U.S. FDA Approval of MAVYRET (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT 1-6) in as Short as 8 Weeks. Aug 4, 2017 504
AbbVie Receives U.S. FDA Approval of MAVYRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT 1-6) in as Short as 8 Weeks. Aug 3, 2017 1876
FDA approves Mavyret for Hepatitis C. Aug 3, 2017 748
Gilead Receives European Marketing Authorization for Vosevi for Treatment of Chronic Hepatitis C. Jul 31, 2017 279
Enanta to Receive Milestone Payment from AbbVie following Receipt of European Marketing Authorization for Maviret for the Treatment of Chronic Hepatitis. Jul 31, 2017 344
AbbVie's MAVIRET granted European Commission marketing authorisation. Jul 31, 2017 206
AbbVie's MAVIRET granted European Commission marketing authorisation. Jul 31, 2017 202
Association of Interferon Alpha Receptor 1 with sustained virological response in hepatitis C and B co-infected patients. Jul 31, 2017 4038
Assessment of the underlying causes of the immune thrombocytopenia: Ten years experience. Report Jul 31, 2017 3265
Shifa holds awareness seminar on hepatitis. Jul 29, 2017 225
World Hepatitis Day: Study suggests hepatitis C infection most common in North India. Jul 28, 2017 594
The role of screening and treatment in national progress toward hepatitis C elimination--Georgia, 2015-2016. Nasrullah, Muazzam; Sergeenko, David; Gvinjilia, Lia; Gamkrelidze, Amiran; Tsertsvadze, Tengiz; Buts Jul 28, 2017 2770
World Hepatitis Day--June 28, 2017. Jul 28, 2017 250
Hepatitis C emerges as a serious health problem in the country. Jul 28, 2017 376
European Commission grants marketing authorisation for Gilead's Vosevi to treat all genotypes of chronic hepatitis C. Jul 28, 2017 256
European Commission grants marketing authorisation for Gilead's Vosevi to treat all genotypes of chronic hepatitis C. Jul 28, 2017 252
European Commission Grants AbbVie's MAVIRET (glecaprevir/pibrentasvir) Marketing Authorization for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6). Jul 28, 2017 1643
European Commission Grants AbbVie's MAVIRET (glecaprevir/pibrentasvir) Marketing Authorization for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6). Jul 28, 2017 1660
Mylan Launches MyHep All(TM) in India. Jul 27, 2017 874
Mylan introduces MyHep All in India in fixed-dose combination for treating HCV infection. Jul 27, 2017 198
Mylan introduces MyHep All in India in fixed-dose combination for treating HCV infection. Jul 27, 2017 194
Diplomat Now Dispensing VOSEVI(TM) to Treat Chronic Hepatitis C Virus. Jul 26, 2017 730
Supply Of Reagents Necessary For The Detection Of Nucleic Acids Of Hepatitis C Virus (hcv), Human Immunodeficiency Virus (hiv) And Hepatitis B Virus (hbv) In Blood Donors. Jul 21, 2017 165
US FDA grants approval to Gilead Sciences' Vosevi. Jul 20, 2017 236
US FDA grants approval to Gilead Sciences' Vosevi. Jul 20, 2017 232
Gilead's chronic hepatitis C virus drug approved by FDA. Jul 19, 2017 174
Gilead's chronic hepatitis C virus drug approved by FDA. Jul 19, 2017 170
FDA approves Vosevi for Hepatitis C. Jul 18, 2017 747
Literature review & commentary. Gaby, Alan R. Jul 1, 2017 2457
Curing the incurable: new combination of anti-viral drugs show promising results in veterans infected with hepatitis C. Dever, Mary Jul 1, 2017 512
A Wisconsin health study: identifying chronic HCV infection in boby-boomer inmates. Greer, James; Wedig, Mary; Prieve, Audrey; Stockman, Lauren J. Jul 1, 2017 1576
Hepatitis C is a pediatric disease now. Bryant, Krishna K. Jul 1, 2017 1309
Suicidal and paranoid thoughts after starting hepatitis C virus treatment. Banerjee, Arpita Goswami; Retamero, Carolina; Mehta, Sachin Case study Jul 1, 2017 1817
Concurrent infection with hepatitis C Virus and Streptococcus pneumoniae. Marrie, Thomas J.; Tyrrell, Gregory J.; Majumdar, Sumit R.; Eurich, Dean T. Jul 1, 2017 4732
Adams-Oliver syndrome: A case report. Jun 30, 2017 1202
Chemical Constituents and Antiviral Activity from Marine Endophytic Fungi from Red Sea Alga Padina pavonica. Report Jun 30, 2017 4124
Treatment of chronic Hepatitis C in Thalassemia major patients. Report Jun 30, 2017 2202
Screening of adult dental patients visiting Khyber College of Dentistry, Peshawar for HBV and HCV infections and identifying the associated risk factors. Jun 30, 2017 4195
Gilead's Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) Receives Positive Opinion from European CHMP for Treatment Chronic HCV Infection. Jun 26, 2017 303
CHMP Issues Positive Opinion for Maviret for the Treatment of Chronic Hepatitis C. Jun 26, 2017 343
United States : European CHMP Adopts Positive Opinion for Gileads Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) for the Treatment of All Chronic Hepatitis C Genotypes. Jun 24, 2017 525
AbbVie Receives CHMP Positive Opinion for MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6). Jun 23, 2017 1304
AbbVie Receives CHMP Positive Opinion for MAVIRET(TM) (glecaprevir/pibrentasvir) for the Treatment of Chronic Hepatitis C in All Major Genotypes (GT1-6). Jun 23, 2017 1308
Few states fully support HCV prevention, treatment. Franki, Richard Jun 15, 2017 469
Supply Of Hcv Rapid Test Kit Hepatitis C Virus. Jun 15, 2017 108
Supply Of Hcv Rapid Test Kit Hepatitis C Virus. Jun 15, 2017 103
IBBR wins USD6m NIH grant for structure-based Hepatitis C Vaccine design. Jun 13, 2017 248
IBBR wins USD6m NIH grant for structure-based Hepatitis C Vaccine design. Jun 13, 2017 244
IBBR Awarded $6 Million NIH Grant for Structure-Based Design of a Hepatitis C Vaccine. Jun 12, 2017 872
Copharix(TM) initiates launch of Chronic Care and HCV services in 33 states across USA. Jun 12, 2017 1063
Hepatitis C virus, tumors cost Egypt LE 3.3B in 2016. Jun 11, 2017 356
Opdivo, Eliquis drive growth for BMS: several new products offset competition while others struggle. Jun 1, 2017 1689
HCV pregnancy increase suggests need for broader screening. Otto, M. Alexander Jun 1, 2017 301
Chronic Hepatitis C and people with a history of injecting drugs in Spain: population assessment, challenges for effective treatment/Hepatitis C Cronica y usuarios con un historial de inyeccion de drogas en Espana: evaluacion de la poblacion, retos para un tratamiento efectivo. Carlos, Roncero; Pablo, Vega; Jose, Martinez-Raga; Marta, Torrens Jun 1, 2017 1455
Using network sampling and recruitment data to understand social structures related to community health in a population of people who inject drugs in rural Puerto Rico. Coronado-Garcia, Mayra; Thrash, Courtney R.; Welch-Lazoritz, Melissa; Gauthier, Robin; Reyes, Juan C Jun 1, 2017 5762
Bioinformatics techniques used in Hepatitis C virus research. Kaushik, Vikas; Singh, Bhupender; Singh, Joginder Report Jun 1, 2017 7017
Sisi orders completing HCV treatment within a year. May 23, 2017 446
Global Hepatitis C Disease Forecast and Market Analysis 2017-2035: Clinical Pipeline Overview, Marketed Drugs and Early-Phase Opportunities - Research and Markets. May 19, 2017 513
Global Hepatitis C Disease Forecast and Market Analysis 2017-2035: Clinical Pipeline Overview, Marketed Drugs and Early-Phase Opportunities - Research and Markets. May 19, 2017 553
Consultancy To Support The Hcv Normative Guideline Development Process. May 16, 2017 488
Hepatitis awareness month and testing day--May 2017. May 12, 2017 308
State HCV incidence and policies related to HCV preventive and treatment services for persons who inject drugs--United States, 2015-2016. Campbell, Cecily A.; Canary, Lauren; Smith, Nicole; Teshale, Eyasu; Ryerson, A. Blythe; Ward, John W May 12, 2017 2522
Hepatitis C virus infection among women giving birth--Tennessee and United States, 2009-2014. Patrick, Stephen W.; Bauer, Audrey M.; Warren, Michael D.; Jones, Timothy F.; Wester, Carolyn May 12, 2017 2889
New Hepatitis C Infections Nearly Tripled over Five Years. May 11, 2017 1089
Study Identifies Genetic Markers that Predict Which Patients with Hepatitis C and Cirrhosis Will Improve with Treatment. Report May 9, 2017 478
HCV patients to receive free treatment: Health Ministry spox. May 7, 2017 127
Upper Egypt gov't campaign diagnose 132k people with HCV. May 5, 2017 234
Hepatitis Therapeutics Market Size Worth $25.8 Billion By 2025: Grand View Research, Inc. May 1, 2017 914
Hepatitis Therapeutics Market Size Worth $25.8 Billion By 2025: Grand View Research, Inc. May 1, 2017 921
PREVALENCE OF DIFFERENT SONOGRAPHIC STAGES AMONG NEWLY DIAGNOSED CASES OF CHRONIC HEPATITIS C. Apr 30, 2017 3734
Seroprevalence of transfusion transmitted infections among different blood group donors at Blood Bank LUMHS, Hyderabad. Report Apr 30, 2017 2455
China FDA Approves All-Oral Regimen for Chronic Hepatitis C, with Bristol-Myers Squibb's Daklinza and Sofosbuvir. Apr 28, 2017 511
Next Generation HCV Therapy Presented at the International Liver Congress(TM) 2017 by Texas Liver Institute's Dr. Fred Poordad. Clinical report Apr 27, 2017 816
Saudi Arabia Commercial Vehicles (LCV, Bus, MCV and HCV) Market Forecast & Opportunities, 2021 - Research and Markets. Apr 25, 2017 522
Saudi Arabia Commercial Vehicles (LCV, Bus, MCV and HCV) Market Forecast & Opportunities, 2021 - Research and Markets. Apr 25, 2017 562
Update on the Development of Simeprevir as Part of the Triple Combination With AL-335 and Odalasvir (JNJ-4178). Apr 24, 2017 484
AbbVie's HCV study of glecaprevir/pibrentasvir achieves 99% cure rate. Apr 24, 2017 235
AbbVie's HCV study of glecaprevir/pibrentasvir achieves 99% cure rate. Apr 24, 2017 231
United States : Real-World Observational Study in the U.S. Veterans Affairs System Evaluating Use of Mercks ZEPATIER (Elbasvir and Grazoprevir) Shows High Sustained Virologic Response Rates in Patients with Chronic Hepatitis C. Apr 22, 2017 514
New hepatitis data highlight need for urgent global response -- WHO. Apr 21, 2017 945
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR(12) Rates in Challenging to Treat Genotype 3 Chronic Hepatitis C. Apr 21, 2017 1807
Doubt expressed about potential of any single regimen to treat all hep C. Bosworth, Ted Apr 15, 2017 743
Viral eradication is the primary goal in HCV Treatment - Wasim Jafari. Report Apr 15, 2017 1509
US FDA grants approval to Gilead Sciences' Harvoni and Sovaldi. Apr 11, 2017 201
US FDA grants approval to Gilead Sciences' Harvoni and Sovaldi. Apr 11, 2017 197
The US FDA announces approval for two hepatitis C drugs Sovaldi and Harvoni for pediatric patients. Apr 10, 2017 385
The US FDA announces approval for two hepatitis C drugs Sovaldi and Harvoni for pediatric patients. Apr 10, 2017 381
US FDA Approves New Indications for Harvoni, Sovaldi in Pediatric Chronic Hepatitis C Patients 12 Years and Older. Apr 10, 2017 404
HCV testing stagnant among baby boomers. Kling, Jim Apr 1, 2017 606
Hepatitis C virus infection 'cure' within the VA appears likely. Moon, Mary Ann Apr 1, 2017 559
Novel drugs approved in 2016. Briggs, Gerald G. Apr 1, 2017 1979
FREQUENCY OF HEPATITIS B, HEPATITIS C AND HUMAN IMMUNODEFICIENCY VIRUSES IN INTERNALLY DISPLACED PERSONS OF SOUTH WAZIRISTAN, PAKISTAN. Report Mar 31, 2017 4558
Silent killers: Transfusion Transmissible Infections-TTI, among asymptomatic population of Pakistan. Report Mar 31, 2017 4561
PepsiCo launches Hepatitis C awareness campaign. Mar 31, 2017 380
A comparative study of clinico-immunological response to highly Active antiretroviral therapy in HIV and HIV-HCV co-infection in Manipur. Mangar, Amrita; Thongam, Narmada; Singh, Thongam Bhimo; Singh, Karam Romeo; Singh, R.K. Narendra Report Mar 23, 2017 2839
MRC Technology licenses antibody to Newsummit Biopharma. Mar 15, 2017 248
MRC Technology licenses antibody to Newsummit Biopharma. Mar 15, 2017 244
Japanese Ministry of Health, Labour and Welfare Grants Priority Review for AbbVie's Investigational HCV Regimen. Mar 14, 2017 494
Initial HCV test results false positive in almost half of population. Franki, Lucas Mar 1, 2017 220
Sofosbuvir with velpatasvir beat other HCV genotype 3 regimens. Karon, Amy Mar 1, 2017 530
Extrahepatic manifestations of chronic hepatitis C infection: a consecutive study in Brazilian patients. Tengan, Fatima M.; Levy-Neto, Mauricio; Miziara, Ivan D.; Dantas, Bianca P.; Maragno, Luciana Letter to the editor Mar 1, 2017 1025
FREQUENCY AND RISK FACTORS OF HEPATITIS C VIRUS IN PREGNANT WOMEN ATTENDING MILITARY HOSPITAL RAWALPINDI. Feb 28, 2017 2298
TRANSFUSION TRANSMISSIBLE INFECTIONS AMONG HEALTHY BLOOD DONORS AT BLOOD BANK FROM CHILDREN'S HOSPITAL and INSTITUTE OF CHILD HEALTH LAHORE. Feb 28, 2017 3157
Sofosbuvir based therapy in Hepatitis C patients with and without cirrhosis: Is there difference? Feb 28, 2017 3290
Initial results of efficacy and safety of Sofosbuvir among Pakistani Population: A real life trial Hepatitis Eradication Accuracy Trial of Sofosbuvir (HEATS). Feb 28, 2017 3220
ROUTES OF HEPATITIS C TRANSMISSION: AWARENESS AMONG HEALTHY CONTROLS AND HEPATITIS C PATIENTS. Feb 28, 2017 2621
AbbVie's Viekirax + Exviera gets CHMP positive opinion for eight-week treatment of GT1b HCV. Feb 28, 2017 245
AbbVie's Viekirax + Exviera gets CHMP positive opinion for eight-week treatment of GT1b HCV. Feb 28, 2017 241
CHMP Grants Positive Opinion for an Eight-Week Treatment Option of Exviera with AbbVie's Viekirax for Patients with Genotype 1b Chronic Hepatitis C. Feb 28, 2017 563
AbbVie wins priority review for hepatitis C drug. Feb 27, 2017 111
FDA Grants PMA Approval for US Diagnostics Firm Hologic's Aptima Hepatitis C Quant Dx Assay. Feb 17, 2017 317
Watch for skin reactions from new cancer, hepatitis C drugs. Splete, Heidi Feb 15, 2017 358
US FDA Grants Priority Review to AbbVie's Investigational HCV Regimen. Feb 3, 2017 349
NICE publishes final guidance recommending Gilead's Epclusa as hepatitis C treatment option. Jan 26, 2017 233
NICE publishes final guidance recommending Gilead's Epclusa as hepatitis C treatment option. Jan 26, 2017 229
European Medicines Validates Gilead's Marketing Authorization Application for Investigational Chronic Hepatitis C Therapy. Jan 24, 2017 321
European Medicines Validates AbbVie's Marketing Authorisation Application for Investigational HCV Regimen of Glecaprevir/Pibrentasvir for Chronic Hepatitis C. Jan 24, 2017 793
Association between oral lichen planus and hepatitis C: retrospective study and case report/Associacao entre liquen plano oral e hepatite C: estudo retrospectivo e relato de caso. da Silva, Camila Strada; Jacomacci, Willian Pecin; Borges Junior, Helder Fernando; Iwaki, Lilian Cri Ensayo Jan 1, 2017 3902
Genotype Distribution of Hepatitis C Virus in West Sumatera, Indonesia. Report Dec 31, 2016 2264
Seroprevalence of Hepatitis C Virus Infection in Kohat Division, KhyberPakhtoonkhwa, Pakistan. Ullah, Mati; Hasan, Fariha; Najmudin; Alam, Muhammad Masroor; Zaidi, Syed Sohail Zahoor; Rana, Muham Report Dec 31, 2016 3146
COMPARISON BETWEEN ELISA AND ICT TECHNIQUES FOR THE DETECTION OF ANTI HCV ANTIBODY AMONG BLOOD DONORS. Report Dec 31, 2016 2953
Achillion awarded USD15m milestone for initiation of JNJ-4178 in phase 2B development for non-cirrhotic chronic HCV subjects. Dec 29, 2016 227
Achillion awarded USD15m milestone for initiation of JNJ-4178 in phase 2B development for non-cirrhotic chronic HCV subjects. Dec 29, 2016 223
AbbVie submits NDA with the US FDA for investigational glecaprevir/pibrentasvir (G/P) for treating chronic hepatitis C virus. Dec 20, 2016 355
AbbVie submits NDA with the US FDA for investigational glecaprevir/pibrentasvir (G/P) for treating chronic hepatitis C virus. Dec 20, 2016 351
Gilead Sciences submits New Drug Application for combination hepatitis C virus remedy to US FDA. Dec 12, 2016 224
Gilead Sciences submits New Drug Application for combination hepatitis C virus remedy to US FDA. Dec 12, 2016 220
Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs--United States. Wejnert, Cyprian; Hess, Kristen L.; Hall, H. Irene; Van Handel, Michelle; Hayes, Demorah; Fulton, Pa Dec 2, 2016 5051
Frequency of different types of gastric varices in patients with cirrhosis due to chronic hepatitis C. Nov 30, 2016 2114
Regression of hepatocellular carcinoma after treatment with Sofosbuvir - A case report. Nov 30, 2016 1645
Global Viral Molecular Diagnostics Market Analysis and Trends- Application (Hepatitis C virus (HCV),Genetics and Blood Screening), Technology, End User - Forecast to 2025. Nov 24, 2016 659
India Automotive Components Market By Vehicle Type (PC, LCV, M & HCV, 2W, 3W & OTR), By Demand Category (OEM vs Replacement), By Component Type (Engine Parts, Body & Chassis, Suspension & Brakes, etc.), Competition Forecast and Opportunities, 2011 - 2021. Nov 23, 2016 604
AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Shows High SVR Rates in Chronic Hepatitis C Patients with Severe Chronic Kidney Disease. Nov 15, 2016 1588
US Automotive Brake Pads, Shoes and Linings Market, By Vehicle Type (Passenger Car, LCV, M&HCV, etc.), By Demand Category (OEM Vs. Replacement), By Brake Type (Brake Pads, Shoes, etc.) Competition Forecast and Opportunities, 2011 - 2021. Nov 14, 2016 624
Hamdan bin Rashid Al Maktoum Award winners announced. Awards list Nov 14, 2016 499
Eight Weeks of Treatment with AbbVie's Investigational, Pan-Genotypic Regimen of Glecaprevir/Pibrentasvir (G/P) Achieved High SVR Rates Across All Major Genotypes of Chronic Hepatitis C. Nov 11, 2016 1742
New Combination Therapy Could Cure Hepatitis C With Only 4 Weeks of Treatment. Nov 11, 2016 930
3 Years: The Time It Could Take To Cure Nearly Every Veteran With Hepatitis C. Nov 11, 2016 1245
Is There an Increased Risk of Cancer After Taking Direct-Acting Antiviral Medication? Nov 11, 2016 1163
Free CME workshop series helps address the increasing public health threat of HCV among people who inject drugs. Nov 3, 2016 638
New cures for chronic hepatitis C: this often-silent virus that can ruin your liver can now be stopped. Nov 1, 2016 867
Risk factors for hepatitis C. Nov 1, 2016 280
Fulminant HBV reactivation associated with HCV treatment. Sullivan, Michele G. Nov 1, 2016 472
Deal snapshot: TIAGEN BIOTECHNOLOGY, HEC PHARMACEUTICAL TO ESTABLISH NEW COMPANY IN CHINA FOR TREATMENT OF CHRONIC HEPATITIS C. Nov 1, 2016 171
TaiGen Biotechnology, HEC Pharmaceutical to Establish New Company in China for Treatment of Chronic Hepatitis C. Oct 31, 2016 642
TaiGen Biotechnology, HEC Pharmaceutical to Establish New Company in China for Treatment of Chronic Hepatitis C. Oct 31, 2016 659
Molecular epidemiology and clinical features of Hepatitis C Virus (HCV) in epidemic areas of Interior Sindh, Pakistan. Report Oct 31, 2016 2040
TaiGen Biotechnology To Establish a New Company With HEC Pharmaceutical in China for Treatment of Chronic Hepatitis C. Oct 30, 2016 882
Supply Of Lab Reagent Pruduct Blood Glucose Reagent, Cholestrol Reagent, Widal Reagent, Hbsag Card, Hcv Card, Vdrl Card, Dengu Ns1 Card. Oct 28, 2016 162
Hepatitis C Virus (hcv) Card. Oct 26, 2016 181
Global Commercial Vehicle Tire Market By Vehicle Type (LCV and M&HCV), By Demand Category (OEM Vs Replacement), By Region (APAC, Americas, Europe & CIS and MEA), Competition Forecast & Opportunities, 2021. Oct 25, 2016 708
United States : Gilead announces SVR12 Rates From Four Phase 3 Studies of a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir and Voxilaprevir in Treatment-Nave and Treatment-Experienced Genotype 1-6 Chronic HCV-Infected Patients. Oct 21, 2016 452
National progress toward hepatitis C elimination--Georgia, 2015-2016. Gvinjilia, Lia; Nasrullah, Muazzam; Sergeenko, David; Tsertsvadze, Tengiz; Kamkamidze, George; Butsa Oct 21, 2016 2566
Ombitasvir/paritaprevir-based HCV regimens work in HIV. Jancin, Bruce Oct 15, 2016 695
Supply Of Reagents For Determination Of Viral Load Hepatitis B Virus (hbv), Hepatitis C Virus (hcv), Human Immunodeficiency Virus Type 1. Oct 12, 2016 118
AbbVie receives breakthrough therapy designation from US FDA to treat patients with hepatitis C virus infection. Oct 4, 2016 217
AbbVie receives breakthrough therapy designation from US FDA to treat patients with hepatitis C virus infection. Oct 4, 2016 213
AbbVie reports US FDA breakthrough therapy designation for investigational HCV regimen. Oct 3, 2016 233
HCV - Are We at the Other Side of the Tunnel? Report Sep 30, 2016 1413
AbbVie's Investigational HCV Regimen Receives U.S. FDA Breakthrough Therapy Designation. Sep 30, 2016 939
United States : AbbVie presents Data on Eight-Week Treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C. Sep 24, 2016 357
United States : Achillion announces 100% SVR12 in the 6-Week and 8-Week Cohorts in Janssen's Phase 2 Trial Evaluating the Triple Combination Treatment Regimen Including Odalasvir, AL-335, and Simeprevir for Genotype 1 Treatment-Nave HCV. Sep 24, 2016 581
AbbVie Presents Data on Eight-Week Treatment of VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) in Patients with Genotype 1b Chronic Hepatitis C. Sep 23, 2016 1778
A prescription for excessive drug pricing: leveraging government patent use for health. Brennan, Hannah; Kapczynski, Amy; Monahan, Christine H.; Rizvi, Zain Sep 22, 2016 37964
Interim results from Trek Therapeutics' Phase 2 study show triple combination therapy achieves 100% SVR4 in genotype 4 HCV patients. Report Sep 15, 2016 649
A federal class action lawsuit was filed July 26 against the Tennessee Department of Corrections, charging that inmates with Hepatitis C (HCV) are routinely denied treatment for the disease. Gajewski, Karen Ann Brief article Sep 1, 2016 140
Gilead's Epclusa STR approved for HCV. Sep 1, 2016 188
Determination of HCV genotypes by direct sequencing method in Kermanshah Province, Western Iran. Hatami-Moghadam, Reza; Alibakhshi, Reza; Sayad, Babak Report Sep 1, 2016 3084
Liver disease signals more frequent in young people with than without HIV. Sep 1, 2016 1496
High HCV levels in 33% of semen samples from men with HIV and HCV. Sep 1, 2016 1528
India Automotive Components Market By Vehicle Type (PC, LCV, M & HCV, 2W, 3W & OTR), By Demand Category (OEM vs Replacement), By Component Type (Engine Parts, Body & Chassis, Suspension & Brakes, etc.), Competition Forecast and Opportunities, 2011 - 2021. Aug 22, 2016 595
Medivir signs license agreement granting rights to MIV-802 to Trek Therapeutics. Aug 18, 2016 203
Medivir signs license agreement granting rights to MIV-802 to Trek Therapeutics. Aug 18, 2016 199
United States : Results from Mercks Phase 3 Study Evaluating ZEPATIER (elbasvir and grazoprevir) in Patients with Chronic Hepatitis C Receiving Treatment for Opioid Dependence Published in Annals of Internal Medicine. Clinical report Aug 17, 2016 473
Sweden : Medivir licenses rights to MIV-802 to Trek Therapeutics. Aug 17, 2016 223
Sweden : New interim phase IIa data on simeprevir in combination with other DAAs will be presented at the upcoming EASL AASLD Special Conference. Conference news Aug 12, 2016 192
Hepatitis C Screening And Treatment. Aug 9, 2016 375
United States : Results from Mercks Phase 3 Study Evaluating ZEPATIER in Patients with Chronic Hepatitis C Receiving Treatment for Opioid Dependence Published in Annals of Internal Medicine. Clinical report Aug 9, 2016 473
Supply of HCV Card With Seperate Conjugate And Buffer In Test. Aug 4, 2016 107
United States : TREK THERAPEUTICS acquired development & commercialization rights for Lomibuvir & Merimepodib. Aug 3, 2016 228
US Automotive Brake Pads, Shoes and Linings Market, By Vehicle Type (Passenger Car, LCV, M&HCV, etc.), By Demand Category (OEM Vs. Replacement), By Brake Type (Brake Pads, Shoes, etc.) Competition Forecast and Opportunities, 2011 - 2021. Aug 3, 2016 630
Merck receives European Commission approval for Zepatier hepatitis C drug. Aug 2, 2016 143
Merck receives European Commission approval for Zepatier hepatitis C drug. Aug 2, 2016 139
Targeted Testing For Human Immunodeficiency Virus And Hepatitis C Virus. Aug 2, 2016 102
Merck & Co awarded European Commission approval for marketing ZEPATIER for chronic hepatitis C virus (HCV). Aug 1, 2016 307
Merck & Co awarded European Commission approval for marketing ZEPATIER for chronic hepatitis C virus (HCV). Aug 1, 2016 303
4.5% Pakistanis infected with HCV, 2.5% with HBV: Health experts. Jul 29, 2016 479
India : Biocon Initiates "Ek Prayaas" Nationwide Awareness Program on Hepatitis C. Jul 29, 2016 429
United States : CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A). Jul 28, 2016 361
United States : AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C. Jul 28, 2016 350
Prevalence and detection of genotype of hepatitis C virus in chronic renal disease patients undergoing haemodialysis in tertiary care hospital in Punjab. William, Ashish; Oberoi, Aroma; Chopra, Gurvinder Singh; Das, Jasmine Report Jul 28, 2016 3163
Trek Therapeutics acquires global development and commercialisation rights for lomibuvir and merimepodib. Jul 28, 2016 173
Trek Therapeutics acquires global development and commercialisation rights for lomibuvir and merimepodib. Jul 28, 2016 169
New EIU programme highlights successes and opportunities in efforts to tackle Hepatitis C. Jul 28, 2016 903
Hepatitis C Treatment Specialist Trek Therapeutics Acquires Two Vertex Antiviral Inhibitors. Jul 28, 2016 276
Deal snapshot: HEPATITIS C TREATMENT SPECIALIST TREK THERAPEUTICS ACQUIRES RIGHT TO TWO VERTEX ANTIVIRAL INHIBITORS. Jul 28, 2016 123
Hepatitis C Treatment Specialist Trek Therapeutics Acquires Two Vertex Antiviral Inhibitors. Jul 28, 2016 262
Trek Therapeutics Acquires Two Antiviral Inhibitors From Vertex Pharmaceuticals. Jul 26, 2016 552
AbbVie Receives U.S. FDA Approval of Once-Daily VIEKIRA XR(TM) (dasabuvir, ombitasvir, paritaprevir and ritonavir) for the Treatment of Genotype 1 Chronic Hepatitis C. Jul 25, 2016 2852
CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A). Jul 25, 2016 1818
Supply Reagents And Consumables Required For Detection Of Genomic Hepatitis C Virus (hcv), Hiv (hiv) And Hepatitis B Virus (hbv). Jul 23, 2016 249
Increased hepatitis C virus (HCV) detection in women of childbearing age and potential risk for vertical transmission--United States and Kentucky, 2011-2014. Koneru, Alaya; Nelson, Noele; Hariri, Susan; Canary, Lauren; Sanders, Kathy J.; Maxwell, Justine F.; Jul 22, 2016 2517
Global Commercial Vehicle Tire Market By Vehicle Type (LCV and M&HCV), By Demand Category (OEM Vs Replacement), By Region (APAC, Americas, Europe & CIS and MEA), Competition Forecast & Opportunities, 2021. Jul 19, 2016 714
Norway : GENERIC manufacturing licenses for HIV, HCV drugs signed by MPP. Jul 12, 2016 288
Association of lichen planus and hepatitis c virus. Sreedevi, Lekkala; Sreekala, Jinkala; Reddy, Inturi Chandra Sekhar Report Jul 11, 2016 2069
HIV VL & HCV VL Testing Reagents. Jul 8, 2016 164
An overview of HIV and HCV viral load monitoring. Hauenstein, Scott Jul 1, 2016 2172
Supply of laboratory reagents, kits and supplies specific to university hospital queen joanna-isul ead discontinued and new positions according to technical specification . Jul 1, 2016 348
New HCV test approach could cut costs, streamline diagnosis. Perlman, William Jul 1, 2016 310
Biennial Contract For Repair And Maintenance Of HCV, LCV, Trucks, Fire Tenders, Motor Cycles, Mobile Cranes And Material Handling Equipment Etc. At NPCIL RR Site. Jun 30, 2016 151
DOES HEPATITIS C (HCV) TREATMENT - RELATED ANAEMIA PREDICT A GOOD RESPONSE? Jun 30, 2016 2700
Next big threat for Pakistan Hepatocellular Carcinoma (HCC). Jun 30, 2016 3390
Raynaud's phenomenon and bilateral olecranon bursitis co-existing in a patient with chronic hepatitis B and D treated with pegylated interferon. Jun 30, 2016 1906
Overall Uptake and High Prescribing Rate in Retreatment for Gilead's Harvoni Solidify Its Stronghold on the Hepatitis C Market. Jun 29, 2016 737
Diplomat Pharmacy to distribute EPCLUSA to patients living with chronic HCV infection. Jun 29, 2016 193
United States : FDA approves Epclusa for treatment of chronic Hepatitis C virus infection. Jun 29, 2016 592
FDA approves Epclusa for treatment of chronic Hepatitis C virus infection. Jun 28, 2016 773
Diplomat to Dispense EPCLUSA (sofosbuvir/velpatasvir) for the Treatment of Chronic Hepatitis C. Jun 28, 2016 799
Regulus Reports Clinical Hold of RG-101. Jun 27, 2016 1221
Chronic HCV boosts hospitalization risk, not just for liver. Nogrady, Bianca Jun 15, 2016 426
Health Canada approves Daklinza. Jun 6, 2016 138
Investigation of hepatitis C virus transmission associated with injection therapy for chronic pain--California, 2015. Foster, Monique A.; Grigg, Cheri; Hagon, Jaclyn; Batson, Paige A.; Kim, Janice; Choi, Mary; Moorman, Jun 3, 2016 1974
HIV HCV Prevention and Education Services. Jun 2, 2016 309
Hepatitis B infection in HIV-1-infected patients receiving highly active antiretroviral therapy in Lome, Togo: prevalence and molecular consequences. Patassi, A.A.; Benaboud, S.; Landoh, D.E.; Salou, M.; Dagnra, A. Claver; Saka, B.; Krivine, A.; Meri Jun 1, 2016 5048
Frequency of Hepatitis B surface antigen (HBsAg) and Hepatitis C antibody (HCVAb) seropositivity among preoperative eye surgery patients. Lohano, Mahesh Kumar; Su, Li; Narsani, Ashok Kumar; Jawed, Muhammad; Naveed, Hameem Report Jun 1, 2016 2190
On-the-go diagnosis of HIV and HCV co-infections. Jun 1, 2016 469
Belgium : Two new combination therapies against chronic hepatitis C. May 28, 2016 620
United States : Merck Receives Positive CHMP Opinion for ZEPATIER (elbasvir and grazoprevir) in the European Union. May 28, 2016 849
Targeted testing for human immunodeficiency virus and hepatitis c virus. May 23, 2016 103
Jurisdictional approach to curing hepatitis c among hiv/hcv coinfected people of color jurisdictional sites. May 20, 2016 114
Hepatitis C event with free testing. May 18, 2016 131
Travelers Insurance Accused by NFHA of Discrimination against Apartment Owners Renting to Tenants with Housing Choice Vouchers. May 17, 2016 1034
Provision of services by definition (hbsag, total antibodies to hepatitis c virus) in the blood serum. May 17, 2016 404
Establishing cooperation with the platform and / or vlogerami as ambassadors for the campaign of the Project Prevention of HCV infection. May 15, 2016 122
Hepatitis Awareness Month and Testing Day--May 2016. May 13, 2016 307
Identification and clinical management of persons with chronic hepatitis C virus infection--Cherokee Nation, 2012-2015. Mera, Jorge; Vellozzi, Claudia; Hariri, Susan; Carabin, Helene; Drevets, Douglas A.; Miller, Anna; R Disease/Disorder overview May 13, 2016 2659
Birth cohort testing for hepatitis C virus--Indian Health Service 2012-2015. Reilley, Brigg; Leston, Jessica; Hariri, Susan; Neel, Lisa; Rudd, Miles; Galope, Megan; Ward, John; May 13, 2016 2621
HCV ELISA method KIT 3rd gneration:HCV Elisa method kit should be HCV specific recombinant proteins etc. May 12, 2016 133
Targeted testing for human immunodeficiency virus and hepatitis c virus. May 12, 2016 101
Biosortia Pharmaceuticals Announces Three New Oncology Research Projects Using Microbial Compounds. May 6, 2016 991
Targeted Testing for Human Immunodeficiency Virus and Hepatitis C Virus. May 6, 2016 389
Diplomat Celebrates World Hepatitis Month with National Multimedia Campaign. May 3, 2016 737
Trend of hepatitis B and hepatitis C infections in a tertiary care medical institute in eastern India. Laifangbam, Supriya; Preeti, Gurumayum; Khongbantabam, Vyas Report May 2, 2016 3175
Recent HCV genotype changing pattern in the Khyber Pakhtunkhwa province of Pakistan; is it pointing out a forthcoming problem? Afzal, Muhammad Sohail; Shah, Zaheer Hussain; Ahmed, Haroon Report May 1, 2016 843
Hepatitis C virus transmission peaked in 1950. Karon, Amy May 1, 2016 398
Focus on testing, not shifting blame. Spaulding, Anne C.; Miller, Lesley S. May 1, 2016 316
Linkage to care for suburban heroin users with hepatitis C virus infection, New Jersey, USA. Akyar, Eda; Seneca, Kathleen H.; Akyar, Serra; Schofield, Neal; Schwartz, Mark P.; Nahass, Ronald G. Report May 1, 2016 1778
Mediterranean herb guards vital liver functions. Nevis, Linda Report May 1, 2016 4749
Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study. Report Apr 30, 2016 3348
Housing Choice Voucher Success Program Housing Navigators. Apr 27, 2016 486
Automotive Rain Sensor Market by Region (APAC, Europe, North America & Rest of the World), and by Vehicle Type (PC, LCV & HCV) - Trends and Forecast to 2020. Apr 26, 2016 810
United States : AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) without Ribavirin in Genotyp. Apr 26, 2016 524
AbbVie Receives U.S. FDA Approval of Supplemental New Drug Application for VIEKIRA PAK (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets) without Ribavirin in Genotype 1b Chronic Hepatitis C Patients with Compensated Cirrhosis. Apr 25, 2016 2981
Advanced Driver Assistance Systems (ADAS) Market Analysis - By Modules (ACC, TPMS, BSD, LDWS, FCMS, AEB); By Sensors (Image, RADAR, Laser); By Vehicle (Passenger, LCV, HCV) - With Forecast (2015 - 2020). Apr 21, 2016 593
AbbVie Presents New Phase 2 Data for Investigational, Once-Daily, Ribavirin-Free, Pan-Genotypic Regimen of ABT-493 and ABT-530 for Hepatitis C Genotypes 1-6. Apr 16, 2016 2022
United States : Merck Announces Results From Phase 3 Studies of ZEPATIER (Elbasvir and Grazoprevir) in Chronic Hepatitis C Patient Populations at The International Liver Congress. Apr 16, 2016 917
AbbVie Announces Real-World Data with VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA (dasabuvir tablets) from Large German Hepatitis C-Registry. Apr 15, 2016 1688
AbbVie's Investigational, Pan-Genotypic Regimen of ABT-493 and ABT-530 Shows High SVR Rates in Genotype 1 Hepatitis C Patients Who Failed Previous Therapy with Direct-Acting Antivirals. Apr 15, 2016 1082
United States : Mercks ZEPATIER (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Tri. Apr 15, 2016 684
AbbVie Announces High SVR Rates with VIEKIRAX(R) + EXVIERA(R). Apr 14, 2016 265
AbbVie Announces High SVR Rates with VIEKIRAX(R) + EXVIERA(R). Apr 14, 2016 261
Combined HIV, hepatitis C vaccination a possibility soon. Apr 14, 2016 306
Quest Launches New Hepatitis C Virus Test Capabilities for Recently FDA-approved Antiviral Therapies. Apr 14, 2016 1166
Supply of 141.Cresol with Soap Solution142.Diclofenac sodium gel 1%143.Elisa Kit to determine antibodies to HIVI & HIVII in Human Sera/Plasma3rd generation144.Isoflurane145.Miconazole Cream 2 %. Apr 8, 2016 135
Supply, possibly renewable for a further two years for diagnostic systems for the diagnosis of infection with HCMV-DNA, HBV DNA, HCV RNA and HIV1-RNA. Apr 8, 2016 254
New Kaiser Permanente Screening and Care Model Improves Hepatitis C Detection. Apr 6, 2016 1003
Janssen to Unveil New Hepatitis B and C Data at The International Liver Congress(TM) 2016 of the European Association for the Study of the Liver (EASL). Mar 30, 2016 2054
AbbVie to Present Data on VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) and EXVIERA (dasabuvir tablets) and Investigational, Pan-Genotypic Regimen at The International Liver Congress(TM) 2016. Mar 30, 2016 2527
Janssen to Unveil New Hepatitis B and C Data at The International Liver Congress(TM) 2016 of the European Association for the Study of the Liver (EASL). Mar 30, 2016 2061
Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report. Report Mar 30, 2016 878
Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report. Report Mar 30, 2016 884

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters